These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7870870)

  • 1. Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat.
    Gardner EL; Walker LS; Paredes W
    Psychopharmacology (Berl); 1993; 110(1-2):119-24. PubMed ID: 7870870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine produces potent antidopaminergic effects anatomically specific to the mesolimbic system.
    Gardner EL; Chen J; Paredes W
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():15-22. PubMed ID: 7961561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
    Broderick PA; Piercey MF
    J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine's mechanisms of action: non-dopaminergic activity rather than anatomical selectivity.
    Lidsky TI; Banerjee SP
    Neurosci Lett; 1992 May; 139(1):100-3. PubMed ID: 1407675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine's anti-acetylcholine property modulates its antistereotypic action in the mesolimbic system.
    Al-Shabibi UM; Doggett NS
    J Pharm Pharmacol; 1980 May; 32(5):359-61. PubMed ID: 6104704
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
    Seeger TF; Thal L; Gardner EL
    Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine inhibits limbic system kindling: implications for antipsychotic action.
    Graham SR; Kokkinidis L
    Brain Res Bull; 1993; 30(5-6):597-605. PubMed ID: 8096163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobehavioral evidence for mesolimbic specificity of action by clozapine: studies using electrical intracranial self-stimulation.
    Gardner EL; Seeger TF
    Biol Psychiatry; 1983 Dec; 18(12):1357-62. PubMed ID: 6661466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry.
    Lane RF; Blaha CD; Rivet JM
    Brain Res; 1988 Sep; 460(2):398-401. PubMed ID: 2852047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward.
    Benaliouad F; Kapur S; Rompré PP
    Neuropsychopharmacology; 2007 Mar; 32(3):551-61. PubMed ID: 16794561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral evidence of depolarization block of dopamine neurons after chronic treatment with haloperidol and clozapine.
    Boye SM; Rompré PP
    J Neurosci; 2000 Feb; 20(3):1229-39. PubMed ID: 10648727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons.
    Chiodo LA; Bunney BS
    J Neurosci; 1985 Sep; 5(9):2539-44. PubMed ID: 2863337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR; Johnson KM
    J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss.
    Roe DL; Bardgett ME; Csernansky CA; Csernansky JG
    Psychopharmacology (Berl); 1998 Jul; 138(2):151-8. PubMed ID: 9718284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the atypical neuroleptic clozapine on micturition parameters in anesthetized rats.
    Vera PL; Nadelhaft I
    Neurourol Urodyn; 2001; 20(5):623-39. PubMed ID: 11574938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in locomotion and dopamine neurotransmission following amphetamine, haloperidol, and exposure to novel environmental stimuli.
    Bardo MT; Bowling SL; Pierce RC
    Psychopharmacology (Berl); 1990; 101(3):338-43. PubMed ID: 2163539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic action.
    Kapur S; McClelland RA; VanderSpek SC; Wadenberg ML; Baker G; Nobrega J; Zipursky RB; Seeman P
    Neuroreport; 2002 May; 13(6):831-5. PubMed ID: 11997696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with clozapine, but not haloperidol, increases striatal ecto-5'-nucleotidase activity in rats.
    Lara DR; Vianna MR; de Paris F; Quevedo J; Oses JP; Battastini AM; Sarkis JJ; Souza DO
    Neuropsychobiology; 2001; 44(2):99-102. PubMed ID: 11490180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic haloperidol-amphetamine interactions and mesolimbic dopamine.
    Lynch MR; Kuhn HG; Carey RJ
    Neuropsychobiology; 1988; 19(2):97-103. PubMed ID: 3226530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
    Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
    Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.